ArticleScientific reports2022

The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis.

Ngoc Dung Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.